UPDATE: Roth Capital Downgrades Conatus Pharmaceuticals (CNAT) to Neutral
Tweet Send to a Friend
(Updated - March 26, 2019 8:08 AM EDT)
(updated to add analyst comment)Roth Capital analyst Yasmeen Rahimi downgraded Conatus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comment)Roth Capital analyst Yasmeen Rahimi downgraded Conatus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
